Conversion of 2,79,000 warrants in to 2,79,000 Equity Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has converted 2,79,000 convertible warrants into 2,79,000 fully paid equity shares of Rs. 10 face value each. The conversion was done at Rs. 42.25 per share (including Rs. 32.25 premium), and the company received Rs. 88.41 lakh as the balance 75% exercise price. Three non-promoter investors exercised their conversion option, and the company's paid-up equity capital rose from Rs. 16.33 crore to Rs. 16.61 crore. These warrants were originally allotted on a preferential basis in August 2025, and this is a partial conversion — 2,61,000 warrants from Rishabh Sharma and Dipika Patel remain outstanding for future conversion.
This is a routine warrant-to-equity conversion that increases the share count slightly (about 1.7% dilution) and brings in cash, but it is not new fundraising. Existing shareholders may see a small dilutive effect once these new shares are listed for trading.